Evidence map›Paper›PMID 42871857›Full record

ArticleFrontiers in sports and active living2026

From monitoring metrics to decision evidence: validating actionability in applied sport science.

Cyril Besson, Frédéric Stucky

Abstract read
In one paragraph

Article in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cyril Besson *Sports Medicine Center, Swiss Olympic Medical Center, Lausanne University Hospital, Lausanne, Switzerland.
Frédéric Stucky *College of Sports Science and Technology, Mahidol University, Salaya, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In high-performance sport, athlete monitoring and management systems now make physiological, biomechanical, and contextual data easier to collect and share than ever before. Yet it remains unclear whether this expansion has produced better decisions or improved athlete-relevant outcomes. Existing frameworks classify monitoring tools, establish standards for verifying and validating biometric technologies for a stated use, and, increasingly, link patterns of monitoring signals to candidate coaching actions. These advances are necessary, but they do not establish whether valid monitoring information influences decisions or improves the outcomes those decisions are intended to affect. In this Perspective, we argue that actionability should be treated as a claim about decision utility rather than as an inherent property of a metric or monitoring system. We distinguish two levels of evaluation: decision impact, whether monitoring information influences the decision that would otherwise have been made; and outcome evidence, whether the resulting decision improves or protects athlete-relevant outcomes. Practical value also depends on whether a pathway is implemented as intended and whether its benefits justify the burden of implementation. To support evaluation in applied settings, we outline feasible approaches ranging from descriptive audits and decision-impact studies to pragmatic outcome designs. Although our primary focus is high-performance sport, the same decision-evidence logic may extend to health, rehabilitation, and amateur sport. Ultimately, monitoring should be judged by the strength of evidence linking its use to decisions that serve the athlete's best interest.

Indexed as

actionabilityapplied sport scienceathlete monitoringdashboardsdecision-makingmeasurement validityrecoverytraining load

Identifiers

PMID42871857
PMCPMC13661024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.